about
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Read More
3.35
-0.08
(-2.33%)
8,201
XNAS Volume
XNAS 14 Jul, 2025 9:35 AM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Genelux Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..